Epistatic Genetic Determinants of Blood Pressure and Mortality in a Salt-Sensitive Hypertension Model
Although genetic determinants protecting against the development of elevated blood pressure (BP) are well investigated, less is known regarding their impact on longevity. We concomitantly assessed genomic regions of rat chromosomes 3 and 7 (RNO3 and RNO7) carrying genetic determinants of BP without known epistasis, for their independent and combinatorial effects on BP and the presence of genetic determinants of survival using Dahl salt-sensitive (S) strains carrying congenic segments from Dahl salt-resistant (R) rats. Although congenic and bicongenic S.R strains carried independent BP quantitative trait loci within the RNO3 and RNO7 congenic regions, only the RNO3 allele(s) independently affected survival. The bicongenic S.R strain showed epistasis between R-rat RNO3 and RNO7 alleles for BP under salt-loading conditions, with less-than-additive effects observed on a 2% NaCl diet and greater-than-additive effects observed after prolonged feeding on a 4% NaCl diet. These RNO3 and RNO7 congenic region alleles had more-than-additive effects on survival. Increased survival of bicongenic compared with RNO3 congenic rats was attributable, in part, to maintaining lower BP despite chronic exposure to an increased dietary salt (4% NaCl) intake, with both strains showing delays in reaching highest BP. R-rat RNO3 alleles were also associated with superior systolic function, with the S.R bicongenic strain showing epistasis between R-rat RNO3 and RNO7 alleles leading to compensatory hypertrophy. Whether these alleles affect survival by additional actions within other BP-regulating tissues/organs remains unexplored. This is the first report of simultaneous detection of independent and epistatic loci dictating, in part, longevity in a hypertensive rat strain.
- genetic hypertension
- Dahl salt-sensitive rat
- compensatory hypertrophy
- relative wall thickness
Most human morbidity and mortality stem from complex diseases and disorders, of which phenotypes result from interactions of multiple genes with environmental factors. Hypertension is such a disorder, an independent predisposing factor in the development of several diseases responsible for adult morbidity and mortality, including atherosclerosis, coronary heart disease, peripheral artery disease, heart failure, renal failure, and stroke.1 Little is known regarding the relationships between genetic determinants of blood pressure (BP) with genetic determinants of these diseases or overall mortality. We hypothesized that genetic factors contribute to the extended survival of some hypertensive subjects but not others. The obvious difficulty of using death as an end point in studying life span in human hypertensive subjects suggests that hypertension-survival relationships are better studied using animal models.
Inbred Dahl salt-sensitive (SS/Jr or S) and Dahl salt-resistant (SR/Jr or R) rat strains2 are contrasting models of high and relatively normal BP, respectively, selectively bred from outbred Sprague-Dawley rats under salt-loading conditions.3 Supplemental dietary NaCl increases BP in S rats, with little or no effect on BP in R rats. Segregating populations and congenic strains derived from these inbred strains have been used to screen for and confirm chromosomal locations responsible for heritable BP strain differences (ie, BP quantitative trait loci [QTLs]).4,5 S.R congenic strains, and substrains derived from them, were used extensively to identify 11ß-hydroxylase (Cyp11b1) as a genetic determinant of BP on rat chromosome (RNO) 76–8 and to define limits of genomic segments containing BP genetic determinants on other chromosomes.4,9 However, relationships between alleles within BP QTL-containing congenic intervals on different chromosomes have been little studied,10,11 except when epistatic BP QTL interactions were first identified in genome scans. The effects of epistasis between BP QTLs on mortality have not been addressed in previous substitution mapping studies.
In the present study, we assessed rat genomic regions containing BP genetic determinants lacking known epistasis6–8,12 for their independent and combinatorial effects on BP and genetic determinants of survival. These BP QTL-containing intervals showed differing epistatic effects on BP, depending on the duration and concentration of the high-salt diet, and more-than-additive effects on survival, when chronically fed an even higher salt (4% NaCl) diet. Increased survival of RNO3+RNO7 bicongenic, compared with RNO3 congenic, rats was attributable, at least in part, to their maintaining lower BP despite prolonged exposure to a higher dietary NaCl intake. R-rat RNO3 congenic region alleles were also associated with measures of superior systolic function, with epistasis between R-rat RNO3 and RNO7 alleles leading to increased compensatory hypertrophy, as evidenced by increased end-diastolic relative wall thickness (RWT). These data are consistent with our hypothesis that interactions between alleles in different BP QTL-containing regions influence both BP and survival under salt-loading conditions and are traceable using S.R congenic strains as genetic tools.
Inbred and Congenic Rat Strains
Inbred Dahl S and R rat strains were developed2 from outbred stock originally obtained from Dahl.3,13 Development and characterization of rat chromosome 3 and 7 congenic substrains, S.R-(D3Arb14-D3Mco36) and S.R-(D7Mco19-Exon2-Cyp11b1; Figure S1, available in the online Data Supplement at http://www.hypertensionaha.org), were described previously.6,12 Inbred and congenic rat strains were from our colony at the University of Toledo Health Science Campus and will be referred to throughout this manuscript as S, R, RNO3, and RNO7, respectively. Two backcross F1(S×R)×S populations (n=150 rats) were used to examine epistasis between RNO3 and RNO7 loci. Breeding and phenotyping of these populations were described previously14,15 and are summarized in the online Data Supplement.
RNO3 and RNO7 congenic intervals containing R-rat low BP QTL alleles were introgressed into an S-rat genetic background resulting in the S.R-[(D3Arb14-D3Mco36 and D7Mco19-Exon2-Cyp11b1)] rats, hereafter referred to as the RNO3+RNO7 bicongenic strain. Breeding was as follows: F1 rats, bred by crossing RNO3 and RNO7 congenic rats, were backcrossed to RNO3 congenic rats. Progeny heterozygous for the RNO7 and homozygous for the RNO3 congenic intervals were crossed. Resulting progeny homozygous for both congenic intervals were bred to establish the bicongenic strain. All of the breeding and experimental protocols were approved by the institutional animal care and use committee of the University of Toledo Health Science Campus.
Age- and weight-matched rats (group 1: S, n=21; RNO3, n=15; RNO3+RNO7, n=20; and RNO7, n=19) were bred, housed, and studied concomitantly. Rats were weaned at 30 days of age onto a low-salt diet (0.3% NaCl, diet 7034; Harlan-Teklad). Two rats of different strains were randomly assigned to each cage. At 40 to 42 days of age, all of the rats were transferred to a 2% NaCl diet (diet 94217, Harlan-Teklad) for 28 days.
Systolic BP was measured using tail-cuff plethysmography for a subset of group 1 rats (S, n=15; RNO3, n=15; RNO3+RNO7, n=16; and RNO7, n=14) that were conscious, restrained, and warmed to 28°C16 by operators unaware of the rats identity. BP of each rat was measured on consecutive days during weeks 3 (days 17 and 18) and 4 (days 26 and 27) of the 2% NaCl diet. Daily BP values were the mean of 3 to 4 consistent readings. Final BP values were the mean of the daily BP values. After BP measurement (day 28 after initiation of 2% NaCl diet), rats were transferred to a high-salt diet (4% NaCl, diet 83033, Harlan-Teklad) until they died or became obviously terminally ill, in which case they were euthanized by carbon dioxide hypoxia. Rats were examined twice daily for signs of distress.
Two groups of rats were concomitantly bred to further characterize effects of R-rat RNO3 and RNO7 alleles on BP and survival: group 2A (S, n=8; RNO3, n=8; and RNO3+7, n=8) was used to measure BP by telemetry, and group 2B (S, n=23; RNO3, n=10; RNO3+7, n=10; and RNO7, n=10) was used to assess cardiac function by echocardiography and for terminal experiments. Both groups (2A and 2B) received the dietary NaCl regimen described in experiment 1, with renal function assessed by 24-hour urinary protein excretion (UPE). Group 2A rats were fed a 4% NaCl diet until they died or became terminally ill. Group 2B rats were fed a 4% NaCl diet for up to 46 to 48 days, when surviving rats were used in terminal experiments.
Radiotelemetric BP Measurement
Transmitters were surgically implanted into rats 20 to 24 days after initiating the 2% NaCl diet, as described previously.17,18 Rats recovered for a week before BP data was collected. Five sets of BP measurements (systolic and diastolic) were recorded at 5-minute intervals for 24- to 48-hour periods over 12 weeks. For each rat, a series of 6 moving averages (each over a 4-hour period) was calculated over the first 24-hours measured for each time point. An overall mean BP was calculated as the mean of 6 consecutive, 4-hour moving averages, for each of 5 time points measured in a rat.
Urinary Protein Excretion
UPE was determined as described previously.19 Urine was collected 3 times: (1) on a 0.3% NaCl diet, just before administering the 2% NaCl diet; (2) after 27 days on a 2% NaCl diet; and (3) after 38 days on a 4% NaCl diet (a total of 65 days on a higher-salt [2% or 4% NaCl] diet).
Left ventricular (LV) function was evaluated by echocardiography as described previously.20 Briefly, rats were anesthetized with 1.5% to 2.0% isoflurane by O2 inhalation, the chest shaved, and situated in the supine position on a warming pad. 2D guided M-mode studies were performed from parasternal long window using a 15-MHz linear array transducer. Study duration was typically 15 to 20 minutes per rat.
Terminal Experiments and Histology
Group 2B rats surviving 46 days on the 4% NaCl diet (S, n=4; RNO3, n=6, RNO3+RNO7, n=6; and RNO7, n=3) were euthanized by pentobarbital overdose, plasma collected, and body weights measured. After blood collection, hearts were removed, blotted, and weighed. Kidneys were removed, decapsulated, blotted, and weighed separately. Left kidneys and portions of the heart were fixed in 10% neutral-buffered formalin and embedded in paraffin blocks for subsequent sectioning. Plasma glucose, creatinine, and urea nitrogen concentrations were determined by the University of Toledo Medical Center Department of Pathology. Additional details regarding the phenotyping of experiment 2 rats are in the Supplemental Methods available online at http://hyper.ahajournals.org.
Normally distributed data were analyzed by 1-way ANOVA to determine overall significance followed by Tukey honestly significant differences or Games-Howell posthoc tests. Nonparametric data were analyzed by Kruskal-Wallis tests, followed by Mann-Whitney U pairwise comparison tests if significant differences were observed. P<0.05 was the criterion for statistical significance. Data are presented as the means±SEMs.
Equality of the survival functions of the strains was evaluated by Kaplan-Meier and log-rank tests. Survival functions were compared pairwise, with the statistical significance criterion adjusted for multiple comparisons (Bonferroni correction). The effects of R-rat alleles within the RNO3 (R3) and RNO7 (R7) congenic regions on survival in experiment 1 and measures of cardiac and renal function in experiment 2 were examined using general linear models. Additional details are in Supplemental Methods available in the online Data Supplement.
To investigate the relationship between RNO3 and RNO7 BP QTLs, we analyzed the relationship between Cyp11b and Edn3 (near these BP QTL peaks) with BP and body weight (BW)–adjusted heart weight a previously studied F1(S×R)×S backcross population.7,14,15 No interactions were observed between these loci for either trait (Table S1). A bicongenic strain (RNO3+RNO7) was bred to confirm additive actions of R-rat alleles in these congenic regions on BP and to examine effects of these alleles on survival in the context of an excessive dietary NaCl intake.
Less-Than-Additive Effects of RNO3 and RNO7 QTLs on BP
Systolic BP was measured by tail-cuff plethysmography in concomitantly raised male S, RNO3 and RNO7 congenic, and RNO3+RNO7 bicongenic rats during the third and fourth weeks of a 2% NaCl diet (Table 1 and Figure 1A and 1B). These BP measurement sets were strongly correlated (r=0.660; P<0.0001; Figure S2). Compared with the parental S strain, lower BP was observed for all 3 of the congenic strains at both time points (Table 1 and Figure 1A and 1B). Lower BP was observed in RNO3 compared with RNO7 congenic rats (160.5±2.3 versus 170.8±3.3 mm Hg, respectively; P=0.018) and in RNO3+RNO7 bicongenic compared with RNO7 congenic rats in week 4 (157.8±3.2 versus 170.8±3.3 mm Hg, respectively; P=0.013) but not between RNO3+RNO7 bicongenic and RNO3 congenic rats (Table 1). Indeed, the differential BP (Δ BP; ie, mean BP of a congenic strain−mean BP of S) for RNO3+RNO7 bicongenic rats in both weeks 3 and 4 were lower than expected if the RNO3 and RNO7 congenic region low BP QTL alleles had additive effects (Figure 1A and 1B).
Greater-Than-Additive Effects of RNO3 and RNO7 QTLs on Survival Under Salt-Loading Conditions
Because nonadditive BP effects were observed between R-rat alleles within these congenic intervals after 4 weeks on a 2% NaCl diet, our primary phenotypic measurement, we examined their effects on longevity after chronic salt loading. All of the rats (including some whose BP were not measured) were fed a higher-salt (4% NaCl) diet. RNO3 and RNO3+RNO7 strains survived significantly longer (96.9±7.1 and 126.4±8.5 days; P=0.002 and P<0.0001, respectively) compared with the parental S strain (64.8±6.4 days; Table 1). Survival differences were not observed between RNO7 and S rats, although RNO7, compared with RNO3, rats survived significantly fewer days (Table 1). Surprisingly, differential survival of RNO3+RNO7 (Δ survival; ie, mean survival of a congenic strain−mean survival of S rats, days on 4% NaCl diet) was much greater compared with the sum of the Δ survivals for RNO3 and RNO7 congenic rats, indicating a strong interactive effect (Figure 1C). Survival functions of these 4 rat strains were significantly different (P<0.0001; Figure 2), with all of the pairwise survival function comparisons significantly different (after Bonferroni correction), except for those of RNO7 with RNO3 or S rats.
Effects of RNO3 and RNO7 congenic interval alleles on survival were examined using a general linear model, with BP (measured during week 4 of the 2% NaCl diet) as a covariate. Both RNO3 congenic interval alleles (R3; P=0.037) and main effects interactions (R3×R7; P=0.030; Figure S2), but not RNO7 congenic interval alleles (R7; P=0.11), were associated with BP-adjusted survival. Increased BP-adjusted survival was observed for RNO3+RNO7 rats (115.3 days) compared with S (84.5 days; P=0.020), RNO3 (86.9 days; P=0.009), or RNO7 (78.9 days; P=0.002) rats (Figure S3).
Longer Exposure to Elevated Dietary NaCl Significantly Reduced BP in Bicongenic Compared With RNO3 Congenic Rats
We next sought to identify factors responsible for increased survival of the RNO3+RNO7 bicongenic rats. Despite BP additivity not being observed in congenic rats fed a 2% NaCl diet (Figure 1 and Table 1), we hypothesized that RNO3 and RNO7 BP QTL allelic products might interact in rats maintained longer on a higher-salt (4% NaCl) diet, causing lower BP in bicongenic compared with RNO3 congenic rats. Experiment 2 was conducted to test this hypothesis. Similar to our earlier results (Table 1), S rats had higher BP (systolic and diastolic) compared with both RNO3 and RNO3+RNO7 rats after 27 days on a 2% NaCl diet, with no significant difference observed between RNO3 and RNO3+RNO7 rats (Table S2). However, BP strain differences were observed between RNO3 and RNO3+RNO7 after additional time on a diet with an even higher salt (4% NaCl) content. Lower systolic BP was observed for bicongenic rats compared with RNO3 congenic rats after 38 days (157.7±2.3 versus 169.6±2.1 mm Hg; P=0.0004), 68 days (196.6±3.6 versus 215.6±4.1 mm Hg; P=0.039), and 75 days (203.8±3.7 versus 223.7±4.6 mm Hg; P=0.0003) of salt loading (Figure 3A and Table S2). Similarly, lower diastolic BP was also observed for RNO3+RNO7 compared with RNO3 rats after 38 days of salt loading (110.2±2.0 versus 115.7±1.8 mm Hg; P=0.039; Figure 3B and Table S2). Interestingly, the BP of S and RNO3 congenic (but not bicongenic) rats plateaued, with S rats reaching this level first (Figure 3 and Table S2).
In addition to the above telemetry experiment, we assessed the BP of group 2B rats surviving for 17 to 18 days on a 4% NaCl diet (69 to 70 days on a higher dietary NaCl intake) by tail-cuff plethysmography. The timeline of all of the experiments is given in Figure 3C. RNO3+RNO7 rats had lower BPs compared with S and RNO7 rats (P=0.001 and P=0.015, respectively; Table S3) but not RNO3 rats, which approached significance (P=0.08). Both RNO3 (R3; P=0.002) and RNO7 (R7; P=0.026) congenic interval alleles, but not the main effects interaction (R3×R7; P value not significant), were associated with significant differences in tail-cuff BP.
R-Rat RNO3 Alleles Are Associated With Superior Cardiac Function After Prolonged Exposure to Excessive Dietary NaCl
The cardiac function of group 2B rats surviving 40 to 41 days on a 4% NaCl diet was assessed by echocardiography, with representative M-mode images shown in Figure S4. Overall, inbred and congenic rat strains in this study could be ranked for echocardiographic parameters, from best to worst, as follows: RNO3+RNO7≥RNO3≥S≥RNO7 (Table 2). Measures of systolic function (LV fractional shortening [FS]) and mean velocity of circumferential fiber shortening (Vcf) were similarly improved in RNO3 and RNO3+RNO7 rats compared with S and RNO7 rats (Table 2). Bicongenic rats showed the most cardiac hypertrophy (as determined by RWT and LV RWT) compared with the other tested strains (Table 2). RNO3 congenic interval alleles were associated with significant differences in the following parameters: FS (P=0.0005), Vcf (P=0.0002), RWT (P=0.026), LV end-diastolic diameter (P=0.019), and LV end-systolic diameter (P=0.001; Table 2). Interestingly, RNO3 and RNO7 congenic interval alleles were epistatic for LV end-diastolic diameter (P=0.042) and RWT (P=0.025; Table 2).
Effects of RNO3 and RNO7 Congenic Interval Alleles on Renal Function Were Highly Dependent on Dietary NaCl Intake
Male S, RNO3 and RNO7 congenic, and RNO3+RNO7 bicongenic (groups 2A and 2B) rats were assessed for renal function on 3 dietary NaCl regimens by measuring 24-hour UPE. Because significant strain differences in BW were observed at each urine collection, 24-hour UPE/BW was analyzed. UPE/BW (24-hour) was first measured in rats maintained on a low-salt (0.3% NaCl) diet, with higher 24-hour UPE/BW observed for S and RNO3 rats compared with RNO3+RNO7 and RNO7 rats (P≤0.001; Table 3), with RNO7 congenic interval alleles associated with differences in 24-hour UPE/BW (P<0.0001; Table 3). However, after 28 days on a higher-salt (2% NaCl) diet, S and RNO7 rats had higher 24-hour UPE/BW compared with RNO3 and RNO3+RNO7 rats (P<0.01; Table 3), with RNO3 congenic interval alleles associated with 24-hour UPE/BW differences (P<0.0001). After 38 days on a 4% NaCl diet, RNO3 rats had lower 24-hour UPE/BW compared with RNO3+RNO7 rats (P=0.012; Table 3) with RNO7 congenic interval alleles associated with 24-hour UPE/BW differences (P=0.042).
Terminal Morphometric and Biochemical Assessment of Inbred and Congenic Rats
No significant strain differences in body, kidney, or heart weights were observed (Table S4). There were also no significant strain differences in circulating creatinine, glucose, or urea nitrogen values (Table S4). However, mean circulating creatinine values for all 4 of the strains were higher than the rat reference range,21 as were mean circulating urea nitrogen values for all but bicongenic rats.
S, RNO3 and RNO7 congenic, and RNO3+RNO7 bicongenic rat kidney sections showed similar, extensive renal vascular changes, consistent with the presence of malignant hypertension (data not shown). Similarly, heart sections from these inbred and congenic strains were evaluated for arterial stenosis, hypertrophic myocytes, and interstitial fibrosis. No strain differences were observed among these 4 strains for these 3 phenotypes (Table S5).
Over the past 2 decades, hundreds of QTLs for BP and related traits have been identified in rodent models and humans,4,5,22–24 although few were characterized with respect to either interaction with other BP QTLs or effects on mortality. Two QTLs for survival in the context of an excessive dietary NaCl intake were identified in the present study. RNO3 congenic rats carried a newly identified survival QTL, whereas R-rat RNO7 congenic interval alleles did not independently affect survival. The latter contrasts with our previous results, where in males, R-rat RNO7 alleles within a much larger congenic region (Figure S1) significantly increased survival compared with S rats.14 However, in the present study, R-rat RNO7 alleles were associated with increased survival under salt-loading conditions in RNO3+RNO7 bicongenic rats, where their products could interact with those of R-rat RNO3 alleles.
Dietary NaCl, Epistasis, and BP
Surprisingly, low BP QTL alleles within the RNO3 and RNO7 congenic intervals of bicongenic rats showed BP epistasis highly dependent on the content and/or duration of exposure to a high dietary NaCl intake (Tables 1 and S2 and Figure 1 and 3⇑). In these RNO3+RNO7 bicongenic rats, less-than-additive effects were observed after a 2% NaCl diet compared with the greater-than-additive effects observed with additional, prolonged exposure to a higher-salt (4% NaCl) diet. Also, when BP was measured under our standard conditions (ie, after 4 weeks on a 2% NaCl diet), low BP QTL alleles in RNO3+RNO7 rats showed less-than-additive effects in contrast with the greater-than-additive effects observed previously in another bicongenic rat strain.10,25 The differing interactive effects of low BP QTL alleles on different chromosomes observed in these 2 bicongenic strains further reflects the intricate gene-environment relationships in complex traits like BP.
R-rat RNO7 congenic interval alleles demonstrated modest BP effects in this study compared with the much larger BP and survival affects of the R-rat RNO7 alleles in S.R-Cyp11b,14 from which it was derived. This suggests that S.R-Cyp11b rats carried additional R-rat RNO7 BP QTL and survival QTL allele(s). Substitution mapping8 suggests that the additional RNO7 low BP QTL allele(s) in S.R-Cyp11b congenic rats14 do not act independently of those of the RNO7 congenic substrain6 used in this study.
Overall, it is clear that BP alone does not completely explain the observed extended survival of the bicongenic rats. There may be factors within and/or outside the cardiovascular and renal systems that dictate the extended survival of the bicongenic rats. In this report, we chose to test the hypothesis that differential functionality of the heart and/or kidney may contribute to differences in survival.
Cardiac Function and Survival
Echocardiographic evaluation of cardiac function suggested that RNO3 congenic region alleles were associated with preservation of systolic function under salt-loading conditions (Table 2). RNO3+RNO7 rats displayed superior systolic function (significantly higher FS and Vcf) compared with S rats. However, no FS and Vcf differences were observed between RNO3+RNO7 and RNO3 rats, suggesting that these strains exhibited similar increases in systolic function compared with S rats (Table 2). Furthermore, no epistasis between RNO3 and RNO7 congenic interval alleles was observed for either measure of systolic function (Table 2). In contrast, RNO7 congenic rats did not demonstrate improved systolic function compared with S rats. Together, these data indicate that, under salt-loading conditions, RNO3 congenic region alleles are primarily responsible for the observed increased systolic function of RNO3+RNO7 bicongenic and RNO3 congenic rats compared with S rats.
However, the above systolic function differences do not explain the longer survival of RNO3+RNO7 compared with RNO3 rats. Echocardiographic evaluation found bicongenic rats to have the highest cardiac hypertrophy (as determined by RWT) among the tested strains. This observation, combined with epistasis between RNO3 and RNO7 congenic interval alleles for RWT (Table 2), suggested that greater RWT contributes to the increased longevity of bicongenic rats (Table 2), consistent with previous studies of pressure overload–induced heart failure, where increased survival was observed for rats with greater RWT.26
Renal Function and Survival
Clearly, the inbred and congenic strains used in this study showed heritable differences in renal function. R-rat RNO7 alleles (in bicongenic and RNO7 congenic rats) were associated with decreased UPE/BW (Table 3), compared with strains (S and RNO3 congenic) lacking these alleles, on a low-salt (0.3% NaCl) diet. After exposure to the 2% NaCl diet, this effect disappeared, and, instead, R-rat RNO3 alleles were associated with decreased UPE/BW (Table 3), possibly reflecting the lower BP of RNO3 and bicongenic rats compared with S and RNO7 rats (Figure 3 and Table 1).
Although these differences in measures of renal function may be related to initial BP strain differences, they are unlikely responsible for increased survival of RNO3+RNO7 rats. Treatment with an even higher, 4% NaCl, diet paradoxically led to lower UPE/BW for RNO3 rats compared with RNO3+RNO7 (as well as S and RNO7) rats. Indeed, histological examination of their renal sections after such treatment found similar, substantial renal vascular changes, consistent with malignant hypertension, that were also reflected in high circulating creatinine and urea nitrogen levels in these 4 rat strains (Table S5).
Mortality as a BP QTL Study Criterion
Although genomic regions containing alleles protecting from morbidity and simultaneously increasing longevity are clearly advantageous, few BP QTLs have been tested for effects on survival.14 In this context, whereas transgenic Sprague-Dawley rats overexpressing Npy27 and transgenic Dahl S rats expressing the R-rat Atp1a1 allele28 showed decreased BP and increased survival, other studies did not associate decreased BP with increased survival.29–33 The dual beneficial effects of decreasing morbidity (by lowering BP) and increasing survival suggest that the RNO3 and RNO7 BP QTLs can be viewed as priorities for further genetic dissection.
The genetic contribution to human life span is estimated to be ≈20%.34 However, study designs to identify such genes in humans and to determine whether they remain operational in a morbid human condition, such as hypertension, are limited.35 These newly identified survival QTLs, one acting independently (on RNO3) and the other epistatically (on RNO7), illustrate how available congenic strains can be exploited for dissecting genes underlying life-span differences among hypertensive subjects and facilitate further positional cloning of causative genes. In addition, our study in rat models demonstrates how heritable elements dictating small BP changes in hypertensive subjects can lead to differential mortality through epistatic mechanisms. Because our analysis of the effects of these alleles on cardiac and renal function was limited, it remains to be investigated whether these RNO3 and RNO7 alleles might also exert their effects through actions occurring in other tissues/organ systems involved in the maintenance of BP homeostasis.
We thank the Physiology and Pharmacology Departmental Phenotyping Core for facilitating the echocardiography experiments.
Sources of Funding
This work was supported by grants from the National Heart, Lung, and Blood Institute, National Institutes of Health (RO1-HL020176 and RO1-HL075414) to B.J. and (RO1-HL68994) to G.T.C. and S.J.L.
- Received November 24, 2008.
- Revision received December 21, 2008.
- Accepted January 30, 2009.
Kannel WB, Wolf WFB. Cardiovascular risk factors and hypertension. In: Izzo JI Jr, Black HR, eds. Hypertension Primer. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003: 235–238.
Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000; 80: 135–172.
Joe B, Garrett MR. Genetic analysis of inherited hypertension in the rat. In: Dominiczak A, Connell JM, eds. Genetics of Hypertension. Vol 24. Amsterdam, Netherlands: Elsevier Science; 2006: 177–200.
Rapp JP, Deng AY. Detection and positional cloning of blood pressure quantitative trait loci: is it possible? Identifying the genes for genetic hypertension. Hypertension. 1995; 25: 1121–1128.
Monti J, Plehm R, Schulz H, Ganten D, Kreutz R, Hübner N. Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10. Hum Mol Genet. 2003; 12: 435–439.
Lee SJ, Liu J, Westcott AM, Vieth JA, DeRaedt SJ, Yang S, Joe B, Cicila GT. Substitution mapping in Dahl rats identifies two distinct blood pressure quantitative trait loci within 1.12 Mb and 1.25 Mb intervals on chromosome 3. Genetics. 2006; 174: 2203–2213.
Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in the susceptibility to experimental hypertension. J Exp Med. 1962; 115: 1173–1190.
Buñag R, Butterfield J. Tail cuff blood pressure measurement without external preheating in awake rats. Hypertension. 1982; 4: 898–903.
Toland EJ, Yerga-Woolwine S, Farms P, Cicila GT, Saad Y, Joe B. Blood pressure and proteinuria effects of multiple quantitative trait loci on rat chromosome 9 that differentiate the spontaneously hypertensive rat from the Dahl salt-sensitive rat. J Hypertens. 2008; 26: 2134–2141.
Morgan EE, Faulx MD, McElfresh TA, Kung TA, Zawaneh MS, Stanley WC, Chandler MP, Hoit BD. Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 2004; 287: H2049–H2053.
Joe B, Garrett MR. Substitution mapping: using congenic strains to detect genes controling blood pressure. In: Raizada MK, Paton JFR, Kasparov S, Katovich MJ, eds. Cardiovascular Genomics. Totowa, NJ: Humana Press Inc; 2005: 41–58.
Deng AY. Positional cloning of quantitative trait Loci for blood pressure: how close are we? A critical perspective. Hypertension. 2007; 49: 740–747.
Michalkiewicz M, Knestaut KM, Bytchkova EY, Michalkiewicz T. Hypotension and reduced catecholamines in neuropeptide Y transgenic rats. Hypertension. 2003; 41: 1056–1062.
Pinto YM, Pinto-Sietsma SJ, Philipp T, Engler S, Kossamehl P, Hocher B, Marquardt H, Sethmann S, Lauster R, Merker HJ, Paul M. Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat. Hypertension. 2000; 36: 747–754.
Sironi L, Gelosa P, Guerrini U, Banfi C, Crippa V, Brioschi M, Gianazza E, Nobili E, Gianella A, de Gasparo M, Tremoli E. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J Pharmacol Exper Ther. 2004; 311: 989–995.